What does LORENA BOULANGER PHARMA do?

LORENA BOULANGER PHARMA is a pharmacy in Chapelle-lez-Herlaimont. Private Limited, started on 24 November 2020, 1 establishment.

What is the address of LORENA BOULANGER PHARMA?

The registered office of LORENA BOULANGER PHARMA is located at Rue des Mésanges 5, 7160 Chapelle-lez-Herlaimont.

Is LORENA BOULANGER PHARMA still active?

Yes. According to the CBE (30 October 2026) LORENA BOULANGER PHARMA is active, legal situation “Normale toestand”, started on 24 November 2020.

Is LORENA BOULANGER PHARMA registered on Peppol?

Yes, LORENA BOULANGER PHARMA is registered on the Peppol network with ID 0208:0758731822.

What is the enterprise number of LORENA BOULANGER PHARMA?

The enterprise number of LORENA BOULANGER PHARMA is BE0758731822.

When was LORENA BOULANGER PHARMA founded?

LORENA BOULANGER PHARMA was founded on 24 November 2020.

Who are the directors of LORENA BOULANGER PHARMA?

According to the 2025 annual accounts, the directors of LORENA BOULANGER PHARMA are: LORENA BOULANGER.

Is LORENA BOULANGER PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 24 November 2020; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did LORENA BOULANGER PHARMA make in 2025?

LORENA BOULANGER PHARMA posted a profit after taxes of € 8,065 in financial year 2025.

What is the revenue of LORENA BOULANGER PHARMA?

As a small company, LORENA BOULANGER PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 14,597.

LORENA BOULANGER PHARMA (Private Limited) - BE0758731822

Dossier LORENA BOULANGER PHARMA, printed on 30 October 2026 from databakkes.be/en/0758731822/lorena-boulanger-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

LORENA BOULANGER PHARMA from Chapelle-lez-Herlaimont, company number BE0758731822, closed financial year 2025 with a result of € 8,065 after tax. For that financial year LORENA BOULANGER PHARMA recorded a gross margin of € 14,597 and equity of € 25,925. Compared with financial year 2024, the result moved from € 6,541 to € 8,065. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 2, 2026.

What it is worth Growing

€ 25,925

▲ 45% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 8,065

▲ 23% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 9,404

▲ 120% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 21,925.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Vehicles and equipment

€ 7,852

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

€ 1,303

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 3,406

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 988

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 3,559 Gross margin 2022: € 3,559 First fiscal year in the series	€ 9,564 Gross margin 2023: € 9,564 ▲ 169% vs 2022 (€ 3,559) Favourable step	€ 10,966 Gross margin 2024: € 10,966 ▲ 15% vs 2023 (€ 9,564) Favourable step	€ 14,597 Gross margin 2025: € 14,597 ▲ 33% vs 2024 (€ 10,966) Favourable step	▲ 33%
Profit after taxes	€ 241 Profit after taxes 2022: € 241 First fiscal year in the series	€ 5,583 Profit after taxes 2023: € 5,583 ▲ € 5,342 vs 2022 (€ 241) Favourable step	€ 6,541 Profit after taxes 2024: € 6,541 ▲ 17% vs 2023 (€ 5,583) Favourable step	€ 8,065 Profit after taxes 2025: € 8,065 ▲ 23% vs 2024 (€ 6,541) Favourable step	▲ 23%
Equity	€ 5,737 Equity 2022: € 5,737 First fiscal year in the series	€ 11,319 Equity 2023: € 11,319 ▲ 97% vs 2022 (€ 5,737) Favourable step	€ 17,860 Equity 2024: € 17,860 ▲ 58% vs 2023 (€ 11,319) Favourable step	€ 25,925 Equity 2025: € 25,925 ▲ 45% vs 2024 (€ 17,860) Favourable step	▲ 45%
Total debts	€ 11,126 Total debts 2022: € 11,126 First fiscal year in the series	€ 8,184 Total debts 2023: € 8,184 ▼ 26% vs 2022 (€ 11,126) Favourable step	€ 3,194 Total debts 2024: € 3,194 ▼ 61% vs 2023 (€ 8,184) Favourable step	€ 6,240 Total debts 2025: € 6,240 ▲ 95% vs 2024 (€ 3,194) Unfavourable step	▲ 95%
Cash	€ 10,444 Cash 2022: € 10,444 First fiscal year in the series	€ 6,884 Cash 2023: € 6,884 ▼ 34% vs 2022 (€ 10,444) Unfavourable step	€ 4,267 Cash 2024: € 4,267 ▼ 38% vs 2023 (€ 6,884) Unfavourable step	€ 9,404 Cash 2025: € 9,404 ▲ 120% vs 2024 (€ 4,267) Favourable step	▲ 120%
Retained profit	€ 1,737 Retained profit 2022: € 1,737 First fiscal year in the series	€ 7,319 Retained profit 2023: € 7,319 ▲ € 5,583 vs 2022 (€ 1,737) Favourable step	€ 13,860 Retained profit 2024: € 13,860 ▲ 89% vs 2023 (€ 7,319) Favourable step	€ 21,925 Retained profit 2025: € 21,925 ▲ 58% vs 2024 (€ 13,860) Favourable step	▲ 58%
Bank debt	€ 1,272 Bank debt 2022: € 1,272 First fiscal year in the series	€ 1,308 Bank debt 2023: € 1,308 ▲ 3% vs 2022 (€ 1,272) Unfavourable step	€ 1,309 Bank debt 2024: € 1,309 Unchanged (€ 1,308) Unfavourable step	€ 1,303 Bank debt 2025: € 1,303 Unchanged (€ 1,309) Favourable step
Balance sheet total	€ 16,863 Balance sheet total 2022: € 16,863 First fiscal year in the series	€ 19,503 Balance sheet total 2023: € 19,503 ▲ 16% vs 2022 (€ 16,863) Unchanged	€ 21,054 Balance sheet total 2024: € 21,054 ▲ 8% vs 2023 (€ 19,503) Unchanged	€ 32,165 Balance sheet total 2025: € 32,165 ▲ 53% vs 2024 (€ 21,054) Unchanged	▲ 53%

Key figures of LORENA BOULANGER PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to LORENA BOULANGER PHARMA?

What happened at LORENA BOULANGER PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 2, 2026 New annual accounts for financial year 2025: profit of € 8,065 (▲ 23% vs 2024). Source: NBB ↗
Nov 24, 2020 New establishment in Chapelle-lez-Herlaimont. KBO
2020 LORENA BOULANGER became a director. NBB
Nov 24, 2020 Start of the company according to the CBE. KBO

In short

From € 241 profit in 2022 to € 8,065 profit in 2025.

Paid € 8,473 in corporate taxes since 2022.

Best year ever: 2025, with € 8,065 profit.

Original PDFs at the National Bank ↗

Management

LORENA BOULANGER

LORENA BOULANGER PHARMA

Behind LORENA BOULANGER PHARMA is LORENA BOULANGER.

Directors

According to the 2025 annual accounts

LORENA BOULANGER

Director

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Rue des Mésanges 5

7160 Chapelle-lez-Herlaimont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0758.731.822
VAT number: BE 0758.731.822
Registered office: Rue des Mésanges 5, 7160 Chapelle-lez-Herlaimont
Names & denominations: LORENA BOULANGER PHARMA
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 24 November 2020
Peppol: Active · Active since 30 Dec 2025
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗